208 related articles for article (PubMed ID: 27694435)
1. Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.
Touat-Hamici Z; Weidmann H; Blum Y; Proust C; Durand H; Iannacci F; Codoni V; Gaignard P; Thérond P; Civelek M; Karabina SA; Lusis AJ; Cambien F; Ninio E
Cardiovasc Res; 2016 Dec; 112(3):702-713. PubMed ID: 27694435
[TBL] [Abstract][Full Text] [Related]
2. Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.
Panchatcharam M; Salous AK; Brandon J; Miriyala S; Wheeler J; Patil P; Sunkara M; Morris AJ; Escalante-Alcalde D; Smyth SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):837-45. PubMed ID: 24504738
[TBL] [Abstract][Full Text] [Related]
3. LPP3 localizes LPA6 signalling to non-contact sites in endothelial cells.
Yukiura H; Kano K; Kise R; Inoue A; Aoki J
J Cell Sci; 2015 Nov; 128(21):3871-7. PubMed ID: 26345369
[TBL] [Abstract][Full Text] [Related]
4. Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.
Wu C; Huang RT; Kuo CH; Kumar S; Kim CW; Lin YC; Chen YJ; Birukova A; Birukov KG; Dulin NO; Civelek M; Lusis AJ; Loyer X; Tedgui A; Dai G; Jo H; Fang Y
Circ Res; 2015 Jul; 117(4):e41-e53. PubMed ID: 26034042
[TBL] [Abstract][Full Text] [Related]
5. Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.
Panchatcharam M; Miriyala S; Salous A; Wheeler J; Dong A; Mueller P; Sunkara M; Escalante-Alcalde D; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):52-9. PubMed ID: 23104851
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools.
Long J; Darroch P; Wan KF; Kong KC; Ktistakis N; Pyne NJ; Pyne S
Biochem J; 2005 Oct; 391(Pt 1):25-32. PubMed ID: 15960610
[TBL] [Abstract][Full Text] [Related]
7. Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development.
Chatterjee I; Baruah J; Lurie EE; Wary KK
Cardiovasc Res; 2016 Jul; 111(1):105-18. PubMed ID: 27125875
[TBL] [Abstract][Full Text] [Related]
8. Coronary Artery Disease Risk-Associated
Mueller PA; Yang L; Ubele M; Mao G; Brandon J; Vandra J; Nichols TC; Escalante-Alcalde D; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2261-2272. PubMed ID: 31533471
[TBL] [Abstract][Full Text] [Related]
9. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures.
Humtsoe JO; Liu M; Malik AB; Wary KK
Mol Cell Biol; 2010 Apr; 30(7):1593-606. PubMed ID: 20123964
[TBL] [Abstract][Full Text] [Related]
10. Lipid phosphate phosphatase (LPP3) and vascular development.
Ren H; Panchatcharam M; Mueller P; Escalante-Alcalde D; Morris AJ; Smyth SS
Biochim Biophys Acta; 2013 Jan; 1831(1):126-32. PubMed ID: 22835522
[TBL] [Abstract][Full Text] [Related]
11. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
12. Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development.
López-Juárez A; Morales-Lázaro S; Sánchez-Sánchez R; Sunkara M; Lomelí H; Velasco I; Morris AJ; Escalante-Alcalde D
Glia; 2011 Apr; 59(4):577-89. PubMed ID: 21319224
[TBL] [Abstract][Full Text] [Related]
13. Lipid phosphate phosphatase 3 enables efficient thymic egress.
Bréart B; Ramos-Perez WD; Mendoza A; Salous AK; Gobert M; Huang Y; Adams RH; Lafaille JJ; Escalante-Alcalde D; Morris AJ; Schwab SR
J Exp Med; 2011 Jun; 208(6):1267-78. PubMed ID: 21576386
[TBL] [Abstract][Full Text] [Related]
14. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.
English D; Kovala AT; Welch Z; Harvey KA; Siddiqui RA; Brindley DN; Garcia JG
J Hematother Stem Cell Res; 1999 Dec; 8(6):627-34. PubMed ID: 10645770
[TBL] [Abstract][Full Text] [Related]
15. Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand.
Humtsoe JO; Bowling RA; Feng S; Wary KK
Biochem Biophys Res Commun; 2005 Sep; 335(3):906-19. PubMed ID: 16099422
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration.
Zhang J; Dunk CE; Lye SJ
Hum Reprod; 2013 Nov; 28(11):3026-37. PubMed ID: 24001716
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PLPP3 gene expression by NF-κB family transcription factors.
Mao G; Smyth SS; Morris AJ
J Biol Chem; 2019 Sep; 294(38):14009-14019. PubMed ID: 31362988
[TBL] [Abstract][Full Text] [Related]
19. Lipid phosphate phosphatase 3 in vascular pathophysiology.
Busnelli M; Manzini S; Parolini C; Escalante-Alcalde D; Chiesa G
Atherosclerosis; 2018 Apr; 271():156-165. PubMed ID: 29518748
[TBL] [Abstract][Full Text] [Related]
20. Roles for lysophosphatidic acid signaling in vascular development and disease.
Smyth SS; Kraemer M; Yang L; Van Hoose P; Morris AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158734. PubMed ID: 32376340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
